Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 20/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 9/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 9/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5439639 | 1.00 | CHRM3 (0.54) | CHRM3CHRM2CHRM1 | |
| SCHEMBL5438579 | 0.91 | CHRM3 (0.63) | CHRM3CHRM2CHRM1 | |
| SCHEMBL4165130 | 0.91 | CHRM3 (0.63) | CHRM3CHRM2CHRM1 | |
| SCHEMBL5429532 | 0.82 | CHRM3 (0.44) | CHRM3CHRM2CHRM1 | |
| SCHEMBL4170053 | 0.82 | CHRM3 (0.44) | CHRM3CHRM2CHRM1 | |
| SCHEMBL5431021 | 0.80 | CHRM3 (0.45) | CHRM3CHRM2CHRM1 | |
| SCHEMBL5110174 | 0.78 | CHRM3 (0.49) | CHRM3CHRM2CHRM1 | |
| SCHEMBL5103094 | 0.76 | CHRM3 (0.50) | CHRM3CHRM2CHRM1 | |
| SCHEMBL4157584 | 0.75 | CHRM3 (0.56) | CHRM3CHRM2CHRM1 | |
| SCHEMBL5428922 | 0.75 | CHRM3 (0.56) | CHRM3CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070293531-A1 | Muscarinic Acetycholine Receptor Antagonists | GLAXO GROUP LIMITED (GB) | 2007-12-20 | — | — | US | claimed |
| US-20070293531-A1 | Muscarinic Acetycholine Receptor Antagonists | GLAXO GROUP LIMITED (GB) | 2007-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070293531-A1 | Muscarinic Acetycholine Receptor Antagonists | CHRM3, CHRNA7, CHRNA2 | CHRM3 1/4885CHRM2 7/4885CHRM1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.